Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Quantum Biopharma Ltd Cls B Subordinate Voting S (QNTM.CN)

Quantum Biopharma Ltd Cls B Subordinate Voting S (QNTM.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 19,546
  • Shares Outstanding, K 1,919
  • Annual Sales, $ 0 K
  • Annual Income, $ -14,203 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.16
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.22

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.6300 +13.37%
on 03/25/25
17.5000 -50.57%
on 03/28/25
-1.5500 (-15.20%)
since 03/17/25
3-Month
4.2000 +105.95%
on 01/29/25
25.6400 -66.26%
on 02/06/25
+3.7500 (+76.53%)
since 01/17/25
52-Week
3.9000 +121.79%
on 12/20/24
45.5000 -80.99%
on 04/26/24
-32.9500 (-79.21%)
since 04/17/24

Most Recent Stories

More News
Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario

QNTM : 6.30 (+0.96%)
QNTM.CN : 8.6500 (+1.76%)
Quantum BioPharma Licensee Celly Nutrition Announces Landmark Partnership with the Asian American Trade Associations Council (AATAC) to Expand Retail Availability of its Alcohol Detox Beverage unbuzzdâ„¢

QNTM : 6.30 (+0.96%)
QNTM.CN : 8.6500 (+1.76%)
Quantum BioPharma Licensee Celly Nutrition Launches unbuzzd in Puerto Rico

QNTM : 6.30 (+0.96%)
QNTM.CN : 8.6500 (+1.76%)
Quantum BioPharma Announces Joint Clinical Study With Massachusetts General Hospital Scientists to Validate a Novel Positron Emission Tomography (PET) Imaging Technique to Monitor Demyelination In Multiple Sclerosis

QNTM : 6.30 (+0.96%)
QNTM.CN : 8.6500 (+1.76%)
Quantum Biopharma Announces Closing of Final $2.42 Million Tranche of $5 Million Total Financing on Improved Terms

QNTM : 6.30 (+0.96%)
QNTM.CN : 8.6500 (+1.76%)
Quantum BioPharma Provides Corporate Update

Toronto, Ontario--(Newsfile Corp. - March 30, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building...

QNTM : 6.30 (+0.96%)
QNTM.CN : 8.6500 (+1.76%)
Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern

Completion of unbuzzdTM Clinical Trial and Multiple Sclerosis Drug Lucid-21-302 Phase 1 Trial Advance Company's Pipeline of Products and Assets

QNTM : 6.30 (+0.96%)
QNTM.CN : 8.6500 (+1.76%)
Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern

Completion of unbuzzdTM Clinical Trial and Multiple Sclerosis Drug Lucid-21-302 Phase 1 Trial Advance Company's Pipeline of Products and Assets

QNTM : 6.30 (+0.96%)
QNTM.CN : 8.6500 (+1.76%)
Quantum Biopharma’s 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern

QNTM : 6.30 (+0.96%)
QNTM.CN : 8.6500 (+1.76%)
Quantum Biopharma Announces Leading Crusader Against Naked Short Selling and Stock Manipulation, Terry Lynch Elected to Board of Directors

QNTM : 6.30 (+0.96%)
QNTM.CN : 8.6500 (+1.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development...

See More

Key Turning Points

3rd Resistance Point 8.7333
2nd Resistance Point 8.7167
1st Resistance Point 8.6833
Last Price 8.6500
1st Support Level 8.6333
2nd Support Level 8.6167
3rd Support Level 8.5833

See More

52-Week High 45.5000
Fibonacci 61.8% 29.6088
Fibonacci 50% 24.7000
Fibonacci 38.2% 19.7912
Last Price 8.6500
52-Week Low 3.9000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar